MAM
ACET icon

Meeder Asset Management’s Adicet Bio ACET Stock Holding History

Meeder Asset Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-41
Closed -$5K – 2008
2020
Q1 		$5K Buy
41
+30
+273% +$4.45K ﹤0.01% 1754
2019
Q4 		$2K Buy
11
+8
+267% +$4.05K ﹤0.01% 1983
2019
Q3 		$3K Hold
3
– – ﹤0.01% 1859
2019
Q2 		$3K Buy
+3
New +$2.72K ﹤0.01% 1776

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Meeder Asset Management's ACET Position: Q2 2020 in Review

Meeder Asset Management sold out of Adicet Bio (ACET) in Q2 2020, closing a stake of 41 shares — an estimated $5K sold.

Meeder Asset Management first reported a position in ACET in Q2 2019 and held it in 4 quarters. The position peaked at $5K in Q1 2020. 53 funds tracked by Wall St. Rank hold ACET as of Q2 2020.

  • Meeder Asset Management reported no remaining Adicet Bio position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 41 Adicet Bio shares in Q2 2020, an estimated $5K.
  • Meeder Asset Management first reported a position in Adicet Bio in Q2 2019 and held it in 4 quarters.
  • Meeder Asset Management's Adicet Bio position peaked at $5K in Q1 2020.
  • 53 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.